Clinical-economic impact of mepolizumab in patients with severe hypereosinophilic asthma

Benzer Materyaller

• Clinical-economic impact of mepolizumab in patients with severe hypereosinophilic asthma
  Yazar:: Diego Bagnasco, ve diğerleri
  Baskı/Yayın Bilgisi: (2020-08-01)
• Long-term responsiveness to mepolizumab after failure of omalizumab and bronchial thermoplasty: Two triple-switch case reports
  Yazar:: Carlo Lombardi, ve diğerleri
  Baskı/Yayın Bilgisi: (2020-01-01)
• Evaluation of Clinical Remission in Best-Performing Severe Asthmatic Patients Treated for Three Years with Mepolizumab
  Yazar:: Diego Bagnasco, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-04-01)
• Near-fatal asthma responsive to mepolizumab after failure of omalizumab and bronchial thermoplasty
  Yazar:: Menzella F, ve diğerleri
  Baskı/Yayın Bilgisi: (2017-11-01)
• Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders
  Yazar:: Diego Bagnasco, ve diğerleri
  Baskı/Yayın Bilgisi: (2023-08-01)